Next Biotech Boom May Be Cancer Vaccines: Watch These ETFs
Moderna’s cancer vaccine breakthrough puts biotech, mRNA and genomics ETFs in focus. Here are the funds worth watching.
Stocks · News reference
What’s Going On With Tempus AI Stock on Monday?
Tempus AI stock pulls back after a 20% surge as cancer data spotlights its Personalis deal, and FDA clears its pulmonary hypertension AI tool.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood's Ark Invest added to positions in Nvidia, Broadcom, and Intellia Therapeutics on Friday as these stocks declined. Nvidia exceeded earnings expectations with 106% revenue growth and raised guidance to 70% for fiscal 2028, now trading at 14x forward earnings. Broadcom is on track for accelerating growth with an upcoming earnings report. Intellia, a gene-editing biotech, has declined over 50% from recent highs but remains well-funded with analyst support.
Cathie Wood Keeps Buying Meta on Mark Zuckerberg's Muse Push, Dumps Amazon, AMD, Alphabet, Palantir Amid AI Slowdown Fears
Ark Invest bought Meta on Muse AI optimism while dumping Amazon, AMD, Alphabet and Palantir amid AI slowdown fears on Monday, Sept. 14, 2026.
Billionaire Investor Added SpaceX to His Portfolio Right After the IPO
Dan Loeb’s Third Point acquired 180,415 SpaceX shares worth about $31 million as of June 30, following the company’s Nasdaq debut.
Coinbase CEO Makes Monster Bitcoin Call: $400,000 By 2030
Coinbase (COIN) gains as CEO Brian Armstrong and Needham analysts signal a crypto market bottom and coming U.S. regulatory clarity.
Cathie Wood Buys $28.1 Million Worth of Meta Stock, Dumps Alphabet Shares As Mark Zuckerberg's Superintelligence Vision Takes Shape
Ark Invest bought $28.1 million of Meta and sold $27.9 million of Alphabet on Wednesday, Sept. 9, 2026.